Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.25NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.125NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
G.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.438NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.35NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.178NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.208NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.197NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.491NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EV.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1.8 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.39.3 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BQ.1.8.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.12NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.75.3 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.35NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CY.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FR.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBJ.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CP.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GJ.1.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CK.1.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.56.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7.21NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.7.13.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.37NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CK.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CM.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.1.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.11.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDLNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.17NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.29.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.29.2 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BC.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.10.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.3.13NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.3.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.10.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21398.1Germany
BA.2.56NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.29NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.10NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.112NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.123NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.143NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.29NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.48NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.46.6.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.112.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used